目的 分析2011—2014年內(nèi)蒙古醫(yī)科大學附屬醫(yī)院門診中成藥的使用情況,為臨床合理用藥和計劃采購提供參考。方法 調(diào)取2011—2014年內(nèi)蒙古醫(yī)科大學附屬醫(yī)院門診中成藥的使用數(shù)據(jù)進行回顧性分析,分別從藥物銷售金額、用藥頻度(DDDs)、日均費用(DDC)和藥物利用指數(shù)(DUI)等方面進行統(tǒng)計分析。結(jié)果 2011—2014年銷售金額排名前10位的中成藥占總銷售金額的比例分別為22.15%、21.59%、22.42%、23.15%,并且其品種基本沒有變化,只是排序稍有不同,銷售金額也沒有顯著變化;DDDs排序前10位的中成藥品種變化不大,DDC也相對穩(wěn)定,多數(shù)藥品銷售金額與用藥頻度同步性較差,有待進一步改進。結(jié)論 2011—2014年內(nèi)蒙古醫(yī)科大學附屬醫(yī)院門診中成藥的使用基本合理,但仍存在一些不合理情況,還需進一步加強管理。

Objective To analyze the utilization of Chinese patent medicine in outpatient of Affiliated Hospital of Inner Mongolia Medical University from 2011 to 2014, in order to provide references for clinical rational drug use and scheduled purchasing. Methods The usage of Chinese patent medicine in outpatient department of Affiliated Hospital of Inner Mongolia Medical University from 2011 to 2014 was summarized retrospectively, and consumption sum, defined daily doses (DDDs), average daily cost (DDC), and drug utilization index (DUI) were analyzed statistically. Results The consumption sum of top 10 Chinese patent medicine respectively accounted for 22.15%, 21.59%, 22.42%, and 23.15%. There was nearly no difference among the breeds. Sequences had some differences, but there was no significant difference between consumption sums of top 10 Chinese patent medicines. The kinds of DDDs of top 10 Chinese patent medicines didn't change. DDC was relatively stable. The synchronization of consumption sum and DDDs was poor, and it needed further improvement. Conclusion The utilization of Chinese patent medicine is basically rational in outpatient department of Affiliated Hospital of Inner Mongolia Medical University from 2011 to 2014, but there is still some unreasonable situation, which needs further efforts to strengthen the management.